Skip to main content
SpringerLink
Log in

Role of Omega-3 Fatty Acids in Cardiovascular Disorders

  • Chapter
  • First Online:
Omega-3 Fatty Acids

Abstract

Since the 1970s, there has been mounting evidence regarding the crucial role played by omega-3 fatty acids in the primary and secondary preventions of cardiovascular (CV) events. The omega-3 fatty acids of relevance are the eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) that are obtained from fish oils, and alpha-linolenic acid (ALA) from plant sources such as flaxseed oil. Research has proven their cardio-protective actions improve endothelial function, anti-inflammatory actions, inhibition of platelet aggregation, and regulation of influx and efflux of sodium and calcium channels and triglyceride lowering effects. They also play a role in prevention of heart failure by enhancement of cardiac remodelling. In this review, we discuss the CV benefits of omega-3 fatty acids, detailing their potential mechanisms of action in the prevention of CV mortality and sudden cardiac death. We have outlined the dosages recommended for therapy and have mentioned the reported side effects while presenting a collective overview of the recent randomized controlled trials and analysis on this subject, highlighting both results and limitations.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Kromhout D, Bosschieter EB, de Lezenne Coulander C. The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med. 1985;312:1205–9.

    Article  CAS  PubMed  Google Scholar 

  2. Kris-Etherton PM, Harris WS, Appel LJ. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation. 2002;106:2747–57.

    Article  PubMed  Google Scholar 

  3. Lichtenstein AH, Appel LJ, Brands M, Carnethon M, Daniels S, Franch HA, et al. Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation. 2006;114:82–96.

    Article  PubMed  Google Scholar 

  4. Weintraub H. Update on marine omega-3 fatty acids: management of dyslipidemia and current omega-3 treatment options. Atherosclerosis. 2013;230:381–9.

    Article  CAS  PubMed  Google Scholar 

  5. Pan A, Chen M, Chowdhury R, Wu JH, Sun Q, Campos H, et al. Alpha-linolenic acid and risk of cardiovascular disease: a systematic review and meta-analysis. Am J Clin Nutr. 2012;96:1262–73.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Welch AA, Shakya-Shrestha S, Lentjes MA, Wareham NJ, Khaw KT. Dietary intake and status of n-3 polyunsaturated fatty acids in a population of fish-eating and non-fish-eating meat-eaters, vegetarians, and vegans and the product-precursor ratio [corrected] of alpha-linolenic acid to long-chain n-3 polyunsaturated fatty acids: results from the EPIC-Norfolk cohort. Am J Clin Nutr. 2010;92:1040–51.

    Article  CAS  PubMed  Google Scholar 

  7. Harris WS. Fish oil supplementation: evidence for health benefits. Clevel Clin J Med. 2004;71:208–10.

    Article  Google Scholar 

  8. Flock MR, Harris WS, Kris-Etherton PM. Long-chain omega-3 fatty acids: time to establish a dietary reference intake. Nutr Rev. 2013;71:692–707.

    Article  PubMed  Google Scholar 

  9. Friedman A, Moe S. Review of the effects of omega-3 supplementation in dialysis patients. Clin J Am Soc Nephrol. 2006;1(2):182–92.

    Article  CAS  PubMed  Google Scholar 

  10. Hussein N, Ah-Sing E, Wilkinson P, Leach C, Griffin BA, Millward DJ. Long-chain conversion of [13C] linoleic acid and alpha-linolenic acid in response to marked changes in their dietary intake in men. J Lipid Res. 2005;46:269–80.

    Article  CAS  PubMed  Google Scholar 

  11. Pereira SL, Leonard AE, Huang Y-S, Chuang L-T, Mukerji P. Identification of two novel microalgal enzymes involved in the conversion of the ω3-fatty acid, eicosapentaenoic acid, into docosahexaenoic acid. Biochem J. 2004;384:357–66.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. MaraiI I., Massalha S. Effect of omega-3 polyunsaturated fatty acids and vitamin D on cardiovascular diseases. IMAJ. 2014;16:117–21.

    Google Scholar 

  13. Grimsgaard S, Bønaa KH, Hansen JB, Myhre ESP. Effects of highly purified eicosapentaenoic acid and docosahexaenoic acid on hemodynamics in humans. Am J Clin Nutr. 1998;68(1):52–9.

    CAS  PubMed  Google Scholar 

  14. Mozaffarian D, Wu JHY. Omega-3 fatty acids and cardiovascular disease. Effects on risk factors, molecular pathways, and clinical events. J Am Coll Cardiol. 2011;58(20):2047–67.

    Article  CAS  PubMed  Google Scholar 

  15. Delgado-Lista J, Perez-Martinez P, Lopez-Miranda J. Long chain omega-3 fatty acids and cardiovascular disease: a systematic review. Br J Nutr. 2012;107:S201–13.

    Article  CAS  PubMed  Google Scholar 

  16. Koh KK. Effects of statins on vascular wall: vasomotor function, inflammation, and plaque stability. Cardiovasc Res. 2000;47:648–57.

    Article  CAS  PubMed  Google Scholar 

  17. Koh KK, Han SH, Oh PC, Shin EK, Quon MJ. Combination therapy for treatment or prevention of atherosclerosis: focus on the lipid-RAAS interaction. Atherosclerosis. 2010;209:307–13.

    Article  CAS  PubMed  Google Scholar 

  18. Harris WS, Miller M, Tighe AP, Davidson MH, Schaefer EJ. Omega-3 fatty acids and coronary heart disease risk: clinical and mechanistic perspectives. Atherosclerosis. 2008;197:12–24.

    Article  CAS  PubMed  Google Scholar 

  19. Harris WS, Bulchandani D. Why do omega-3 fatty acids lower serum triglycerides? Curr Opin Lipidol. 2006;17:387–93.

    Article  CAS  PubMed  Google Scholar 

  20. Faeh D, Minehira K, Schwarz JM, Periasamy R, Park S, Tappy L. Effect of fructose overfeeding and fish oil administration on hepatic de novo lipogenesis and insulin sensitivity in healthy men. Diabetes. 2005;54:1907–13.

    Article  CAS  PubMed  Google Scholar 

  21. Clarke SD. Polyunsaturated fatty acid regulation of gene transcription: a molecular mechanism to improve the metabolic syndrome. J Nutr. 2001;131:1129–32.

    CAS  PubMed  Google Scholar 

  22. Rivellese AA, Maffettone A, Iovine C, Di Marino L, Annuzzi G, Mancini M, et al. Long-term effects of fish oil on insulin resistance and plasma lipoproteins in NIDDM patients with hypertriglyceridemia. Diabetes Care. 1996;19:1207–13.

    Article  CAS  PubMed  Google Scholar 

  23. Saraswathi V, Morrow JD, Hasty AH. Dietary fish oil exerts hypolipidemic effects in lean and insulin sensitizing effects in obese LDLR–/– mice. J Nutr. 2009;139:2380–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Jump DB. Fatty acid regulation of hepatic lipid metabolism. Curr Opin Clin Nutr Metab Care. 2011;14:115–20.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Samuel S, Peskin B, Arondekar B, Alperin P, Johnson S, Blumenfeld I, et al. Estimating health and economic benefits from using prescription omega-3 fatty acids in patients with severe hypertriglyceridemia. Am J Cardiol. 2011;108:691–7.

    Article  CAS  PubMed  Google Scholar 

  26. Raitt MH, Connor WE, Morris C, Kron J, Halperin B, et al. Fish oil supplementation and risk of ventricular tachycardia and ventricular fibrillation in patients with implantable defibrillators: a randomized controlled trial. JAMA. 2005;293:2884–91.

    Article  CAS  PubMed  Google Scholar 

  27. Stevenson WG, Stevenson LW, Middlekauff HR, Saxon LA. Sudden death prevention in patients with advanced ventricular dysfunction. Circulation. 1993;88:2953–61.

    Article  CAS  PubMed  Google Scholar 

  28. Campbell RW, Murray A, Julian DG. Ventricular arrhythmias in first 12 hours of acute myocardial infarction. Natural history study. Br Heart J. 1981;46:351–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Leaf A, Kang JX, Xiao YF, Billman GE. Clinical prevention of sudden cardiac death by n-3 polyunsaturated fatty acids and mechanism of prevention of arrhythmias by n-3 fish oils. Circulation. 2003;107:2646–52.

    Article  PubMed  Google Scholar 

  30. Billman GE, Kang JX, Leaf A. Prevention of sudden cardiac death by dietary pure omega-3 polyunsaturated fatty acids in dogs. Circulation. 1999;99:2452–7.

    Article  CAS  PubMed  Google Scholar 

  31. Christensen JH, Riahi S, Schmidt EB, Molgaard H, Kirstein PA, Heath F, et al. n-3 Fatty acids and ventricular arrhythmias in patients with ischaemic heart disease and implantable cardioverter defibrillators. Europace. 2005;7:338–44.

    Article  PubMed  Google Scholar 

  32. Schrepf R, Limmert T, Weber PC, Theisen K, Sellmayer A. Immediate effects of n-3 fatty acid infusion on the induction of sustained ventricular tachycardia. Lancet. 2004;363:1441–2.

    Article  CAS  PubMed  Google Scholar 

  33. Verkerk AO, van Ginneken AC, Berecki G, Den Ruijter HM, Schumacher CA, Veldkamp MW, et al. Incorporated sarcolemmal fish oil fatty acids shorten pig ventricular action potentials. Cardiovasc Res. 2006;70:509–20.

    Article  CAS  PubMed  Google Scholar 

  34. Coronel R, Wilms-Schopman FJ, Den Ruijter HM, Belterman CN, Schumacher CA, Opthof T, et al. Dietary n-3 fatty acids promote arrhythmias during acute regional myocardial ischemia in isolated pig hearts. Cardiovasc Res. 2007;73:386–94.

    Article  CAS  PubMed  Google Scholar 

  35. Saravanan P, Davidson NC, Schmidt EB, Calder PC. Cardiovascular effects of marine omega-3 fatty acids review. Lancet. 2010;375:540–50.

    Article  CAS  Google Scholar 

  36. Leifert WR, Jahangiri A, McMurchie EJ. Membrane fluidity changes are associated with the antiarrhythmic effects of docosahexaenoic acid in adult rat cardiomyocytes. J Nutr Biochem. 2000;11:38–44.

    Article  CAS  PubMed  Google Scholar 

  37. Burr ML, Fehily AM, Gilbert JF, Rogers S, Holliday RM, Sweetnam PM, et al. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet. 1989;344:757–61.

    Article  Google Scholar 

  38. GISSI-Prevenzione Investigators (GruppoItaliano per lo Studio dellaSopravvivenza nell’Infartomiocardico). Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 1999;354:447–55.

    Google Scholar 

  39. Nodari S, Metra M, Milesi G, Manerba A, Cesana BM, Gheorghiade M, et al. The role of n-3 PUFAs in preventing the arrhythmic risk in patients with idiopathic dilated cardiomyopathy. Cardiovasc Drugs Ther. 2009;23:5–15.

    Article  CAS  PubMed  Google Scholar 

  40. Van Wagoner DR. Oxidative stress and inflammation in atrial fibrillation: role in pathogenesis and potential as a therapeutic target. J Cardiovasc Pharmacol. 2008;52:306–13.

    Article  PubMed  CAS  Google Scholar 

  41. Aviles RJ, Martin DO, pperson-Hansen C, Houghtaling PL, Rautaharju P, Kronmal RA, et al. Inflammation as a risk factor for atrial fibrillation. Circulation. 2003;108:3006–10.

    Article  PubMed  Google Scholar 

  42. Rees D, Miles EA, Banerjee T. Dose-related effects of eicosapentaenoic acid on innate immune function in healthy humans: a comparison of young and older men. Am J Clin Nutr. 2006;83:331–42.

    CAS  PubMed  Google Scholar 

  43. Serhan CN, Clish CB, Brannon J, Colgan SP, Gronert K, Chiang N. Anti-microinflammatory lipid signals generated from dietary N-3 fatty acids via cyclooxygenase-2 and transcellular processing: a novel mechanism for NSAID and N-3 PUFA therapeutic actions. J Physiol Pharmacol. 2000;51:643–54.

    CAS  PubMed  Google Scholar 

  44. Serhan CN, Clish CB, Brannon J, Colgan SP, Chiang N, Gronert K. Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal anti-inflammatory drugs and transcellular processing. J Exp Med. 2000;192:1197–204.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Serhan CN, Savill J. Resolution of inflammation: the beginning programs the end. Nat Immunol. 2005;6:1191–7.

    Article  CAS  PubMed  Google Scholar 

  46. Simopoulos AP. Essential fatty acids in health and chronic disease. Am J Clin Nutr. 1999;70(3):560S–9S.

    CAS  PubMed  Google Scholar 

  47. Ross R. Atherosclerosis—an inflammatory disease. N Engl J Med. 1999;340(2):115–26.

    Article  CAS  PubMed  Google Scholar 

  48. MacLean CH, Mojica WA, Morton SC, Pencharz J, Garden RH, Tu W, et al. Effects of omega-3 fatty acids on lipids and glycemic control in type II diabetes and the metabolic syndrome and on inflammatory bowel disease, rheumatoid arthritis, renal disease, systemic lupus erythematosus, and osteoporosis. Evid Rep Technol Assess (Summ). 2004;89:1–4.

    Google Scholar 

  49. Broughton KS, Johnson CS, Pace BK, Liebman M, Kleppinger KM. Reduced asthma symptoms with n-3 fatty acid ingestion are related to 5-series leukotriene production. Am J Clin Nutr. 1997;65:1011–7.

    CAS  PubMed  Google Scholar 

  50. Turner D, Zlotkin SH, Shah PS, Griffiths AM. Omega 3 fatty acids (fish oil) for maintenance of remission in Crohn’s disease. Cochrane Database Syst Rev 2009;(1):CD006320.

    Google Scholar 

  51. Salomon P, Kornbluth AA, Janowitz HD. Treatment of ulcerative colitis with fish oil n-3-omega-fatty acid: an open trial. J Clin Gastroenterol. 1990;12:157–61.

    Article  CAS  PubMed  Google Scholar 

  52. Mayser P, Mrowietz U, Arenberger P, Bartak P, Buchvald J, Christophers E, et al. ω-3 Fatty acid-based lipid infusion in patients with chronic plaque psoriasis: results of a double-blind, randomized, placebo-controlled, multicenter trial. J Am Acad Dermatol. 1998;38:539–47.

    Article  CAS  PubMed  Google Scholar 

  53. Goodfellow J, Bellamy MF, Ramsey MW, Jones CJH, Lewis MJ. Dietary supplementation with marine omega-3 fatty acids improve systemic large artery endothelial function in subjects with hypercholesterolemia. J Am Coll Cardiol. 2000;35(2):265–70.

    Article  CAS  PubMed  Google Scholar 

  54. Schiano V, Laurenzano E, Brevetti G, Isabel D, Malo J, Lanero S, et al. Omega-3 polyunsaturated fatty acid in peripheral arterial disease: effect on lipid pattern, disease severity, inflammation profile, and endothelial function. Clin Nutr. 2008;27(2):241–7.

    Article  CAS  PubMed  Google Scholar 

  55. Haberka M, Mizia-Stec K, Mizia M, Janowska J, Gleszczyk K, Chmiel A, et al. N-3 polyunsaturated fatty acids early supplementation improves ultrasound indices of endothelial function, but not through no inhibitors in patients with acute myocardial infarction: N-3 PUFA supplementation in acute myocardial infarction. Clin Nutr. 2010;30(1):79–85.

    Article  PubMed  CAS  Google Scholar 

  56. Sasaki J, Miwa T, Odawara M. Administration of highly purified eicosapentaenoic acid to statin-treated diabetic patients further improves vascular function. Endocr J. 2012;59(4):297–304.

    Article  CAS  PubMed  Google Scholar 

  57. McVeigh GE, Brennan GM, Cohn JN, Finkelstein SM, Hayes RJ, Johnston GD. Fish oil improves arterial compliance in non-insulin-dependent diabetes mellitus. Arterioscler Thromb. 1994;14(9):1425–9.

    Article  CAS  PubMed  Google Scholar 

  58. Casos K, Zaragoza MC, Zarkovic N, Zarkovic K, Andrisic L, et al. A fish-oil-rich diet reduces vascular oxidative stress in ApoE(–/–) mice. Free Radical Res. 2010;44(7):821–9.

    Article  CAS  Google Scholar 

  59. Robinson JG, Stone NJ. Antiatherosclerotic and antithrombotic effects of omega-3 fatty acids. Am J Cardiol. 2006;98:39i–49i.

    Article  CAS  PubMed  Google Scholar 

  60. de Roos B, Mavrommatis Y, Brouwer IA. Long-chain n-3 polyunsaturated fatty acids: new insights into mechanisms relating to inflammation and coronary heart disease. Br J Pharmacol. 2009;158:413–28.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  61. Mavrommatis Y, Ross K, Rucklidge G, Reid M, Duncan G, Gordon MJ, et al. Intervention with fish oil, but not with docosahexaenoic acid, results in lower levels of hepatic soluble epoxide hydrolase with time in apoE knockout mice. Br J Nutr. 2010;103(1):16–24.

    Article  CAS  PubMed  Google Scholar 

  62. Morris MC, Sacks F, Rosner B. Does fish oil lower blood pressure? A meta-analysis of controlled trials. Circulation. 1993;88:523–33.

    Article  CAS  PubMed  Google Scholar 

  63. McLennan PL. Myocardial membrane fatty acids and the antiarrhythmic actions of dietary fish oil in animal models. Lipids. 2001;36:S111–4.

    Article  CAS  PubMed  Google Scholar 

  64. Billman GE, Kang JX, Leaf A. Prevention of ischemia-induced cardiac sudden death by n-3 polyunsaturated fatty acids in dogs. Lipids. 1997;32:1161–8.

    Article  CAS  PubMed  Google Scholar 

  65. O’Keefe JH Jr, Abuissa H, Sastre A, Steinhaus DM, Harris WS. Effects of omega-3 fatty acids on resting heart rate, heart rate recovery after exercise, and heart rate variability in men with healed myocardial infarctions and depressed ejection fractions. Am J Cardiol. 2006;97:1127–30.

    Article  PubMed  CAS  Google Scholar 

  66. Mozaffarian D, Gottdiener JS, Siscovick DS. Intake of tuna or other broiled or baked fish versus fried fish and cardiac structure, function, and hemodynamics. Am J Cardiol. 2006;97:216–22.

    Article  PubMed  Google Scholar 

  67. Mozaffarian D, Geelen A, Brouwer IA, Geleijnse JM, Zock PL, Katan MB. Effect of fish oil on heart rate in humans: a meta-analysis of randomized controlled trials. Circulation. 2005;112:1945–52.

    Article  CAS  PubMed  Google Scholar 

  68. Biscione F, Pignalberi C, Totteri A, Messina F, Altamura G. Cardiovascular effects of omega-3 free fatty acids. Curr Vasc Pharmacol. 2007;5:163–72.

    Article  CAS  PubMed  Google Scholar 

  69. Das U. Essential fatty acids and their metabolites could function as endogenous HMG-CoA reductase and ACE enzyme inhibitors, antiarrhythmic, antihypertensive, anti-atherosclerotic, anti-inflammatory, cytoprotective, and cardioprotective molecules. Lipids Health Dis. 2008;7:37.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  70. Fischer R, Dechend R, Qadri F, Markovic M, Feldt S, Herse F, et al. Dietary n-3 polyunsaturated fatty acids and direct renin inhibition improve electrical remodeling in a model of high human renin hypertension. Hypertension. 2008;51:540–6.

    Article  CAS  PubMed  Google Scholar 

  71. Kenny D, Warltier DC, Pleuss JA, Hoffmann RG, Goodfriend TL, Egan BM. Effect of omega-3 fatty acids on the vascular response to angiotensin in normotensive men. Am J Cardiol. 1992;70:1347–52.

    Article  CAS  PubMed  Google Scholar 

  72. Harris WS, Rambjor GS, Windsor SL, Diederich D. n-3 fatty acids and urinary excretion of nitric oxide metabolites in humans. Am J Clin Nutr. 1997;65:459–64.

    CAS  PubMed  Google Scholar 

  73. Nestel P, Shige H, Pomeroy S, Cehun M, Abbey M, Raederstorff D. The n-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid increase systemic arterial compliance in humans. Am J Clin Nutr. 2002;76:326–30.

    CAS  PubMed  Google Scholar 

  74. Engler MM, Engler MB, Pierson DM, Molteni LB, Molteni A. Effects of docosahexaenoic acid on vascular pathology and reactivity in hypertension. Exp Biol Med (Maywood). 2003;228:299–307.

    CAS  Google Scholar 

  75. Rasmussen BM, Vessby B, Uusitupa M, Berglund L, Pedersen E, Riccardi G, et al. Effects of dietary saturated, monounsaturated, and n-3 fatty acids on blood pressure in healthy subjects. Am J Clin Nutr. 2006;83:221–6.

    CAS  PubMed  Google Scholar 

  76. Cabo J, Alonso R, Mata P. Omega-3 fatty acids and blood pressure. Br J Nutr. 2012;107:S195–200.

    Article  CAS  PubMed  Google Scholar 

  77. Farzaneh-Far R, Lin J, Epel ES, Harris WS, Blackburn EH, Whooley MA. Association of marine omega-3 fatty acid levels with telomeric aging in patients with coronary heart disease. JAMA. 2010;303(3):250–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  78. Luchtman DW, Song C. Cognitive enhancement by omega-3 fatty acids from child-hood to old age: findings from animal and clinical studies. Neuropharmacology. 2013;64:550–65.

    Article  CAS  PubMed  Google Scholar 

  79. Fedorova I, Hussein N, Baumann MH, Di Martino C, Salem N. An n-3 fatty acid deficiency impairs rat spatial learning in the barnes maze. Behav Neurosci. 2009;123:196–205.

    Article  CAS  PubMed  Google Scholar 

  80. Yamamoto N, Saitoh M, Moriuchi A, Nomura M, Okuyama H. Effect of dietary alpha-linolenate/linoleate balance on brain lipid compositions and learning ability of rats. J Lipid Res. 1987;28:144–51.

    CAS  PubMed  Google Scholar 

  81. Dyall SC, Michael-Titus AT. Neurological benefits of omega-3 fatty acids. Neuromol Med. 2008;10:219–35.

    Article  CAS  Google Scholar 

  82. Tully AM, Roche HM, Doyle R, Fallon C, Bruce I, Lawlor B, et al. Low serum cholesteryl ester—docosahexaenoic acid levels in Alzheimer’s disease: a case-control study. Br J Nutr. 2003;89:483–9.

    Article  CAS  PubMed  Google Scholar 

  83. Lin PY, Chiu CC, Huang SY, Su KP. A meta-analytic review of polyunsaturated fatty acid compositions in dementia. J Clin Psychiatry. 2012;73:1245–54.

    Article  CAS  PubMed  Google Scholar 

  84. Calder PC. The role of marine omega-3 (n-3) fatty acids in inflammatory processes, atherosclerosis and plaque stability. Mol Nutr Food Res. 2012;56(7):1073–80.

    Article  CAS  PubMed  Google Scholar 

  85. Shahzad K, Chokshi A, Schulze PC. Supplementation of glutamine and omega-3 polyunsaturated fatty acids as a novel therapeutic intervention targeting metabolic dysfunction and exercise intolerance in patients with heart failure. Curr Clin Pharmacol. 2011;6(4):288–94.

    Article  CAS  PubMed  Google Scholar 

  86. Wu JH, Micha R, Imamura F, Pan A, Biggs ML, Ajaz O, et al. Omega-3 fatty acids and incident type 2 diabetes: a systematic review and meta-analysis. Br J Nutr. 2012;107(2):S214–27.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  87. Giacco R, Cuomo V, Vessby B, Uusitupa M, Hermansen K, Meyer BJ, et al. Fish oil, insulin sensitivity, insulin secretion and glucose tolerance in healthy people: is there any effect of fish oil supplementation in relation to the type of background diet and habitual dietary intake of n-6 and n-3 fatty acids? Nutr Metab Cardiovasc Dis. 2007;17(8):572–80.

    Article  CAS  PubMed  Google Scholar 

  88. Griffin MD, Sanders TA, Davies IG, Morgan LM, Mill-ward DJ, Lewis F, et al. Effects of altering the ratio of dietary n-6 to n-3 fatty acids on insulin sensitivity, lipoprotein size, and postprandial lipemia in men and postmenopausal women aged 45–70 y: the OPTILIP study. Am J Clin Nutr. 2006;84(6):1290–8.

    CAS  PubMed  Google Scholar 

  89. Villegas R, Xiang YB, Elasy T, Li HL, Yang G, Cai H, et al. Fish, shellfish, and long-chain n-3 fatty acid consumption and risk of incident type 2 diabetes in middle-aged Chinese men and women. Am J Clin Nutr. 2011;94(2):543–51.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  90. Kondo K, Morino K, Nishio Y, Kondo M, Nakao K, Nakagawa F, et al. A fish based diet intervention improves endothelial function in postmenopausal women with type 2 diabetes mellitus: a randomized crossover trial. Metabolism. 2014;63:930–40.

    Article  CAS  PubMed  Google Scholar 

  91. Rizza S, Tesauro M, Cardillo C, Galli A, Iantorno M, Gigli F, et al. Fish oil supplementation improves endothelial function in normoglycemic offspring of patients with type 2 diabetes. Atherosclerosis. 2009;206(2):569–74.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  92. Djousse L, Gaziano JM, Buring JE, Lee IM. Dietary omega-3 fatty acids and fish consumption and risk of type 2 diabetes. Am J Clin Nutr. 2011;93(1):143–50.

    Article  CAS  PubMed  Google Scholar 

  93. van Woudenbergh GJ, van Ballegooijen AJ, Kuijsten A, Sijbrands EJ, van Rooij FJ, Geleijnse JM, et al. Eating fish and risk of type 2 diabetes: a population-based, prospective follow-up study. Diabetes Care. 2009;32(11):2021–6.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  94. Djousse L, Biggs ML, Lemaitre RN, King IB, Song X, Ix JH, et al. Plasma omega-3 fatty acids and incident diabetes in older adults. Am J Clin Nutr. 2011;94(2):527–33.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  95. Akinkuolie AO, Ngwa JS, Meigs JB, Djousse L. Omega-3 polyunsaturated fatty acid and insulin sensitivity: a meta-analysis of randomized controlled trials. Clin Nutr. 2011;30(6):702–7.

    Article  CAS  PubMed  Google Scholar 

  96. Wallin A, Di Giuseppe D, Orsini N, Patel PS, Forouhi NG, Wolk A. Fish consumption, dietary long-chain n-3 fatty acids, and risk of type 2 diabetes: systematic review and meta-analysis of prospective studies. Diabetes Care. 2012;35(4):918–29.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  97. Zheng JS, Huang T, Yang J, Fu YQ, Li D. Marine N-3 polyunsaturated fatty acids are inversely associated with risk of type 2 diabetes in Asians: a systematic review and meta-analysis. PLoS ONE. 2012;7(9):e44525.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  98. Schubert R, Kitz R, Beermann C, Rose MA, Baer PC, Zielen S, et al. Influence of low-dose polyunsaturated fatty acids supplementation on the inflammatory response of healthy adults. Nutrition. 2007;23:724–30.

    Article  CAS  PubMed  Google Scholar 

  99. Bouwens M, van de Rest O, Dellschaft N, Bromhaar MG, de Groot LC, Geleijnse JM, et al. Fish-oil supplementation induces antiinflammatory gene expression profiles in human blood mononuclear cells. Am J Clin Nutr. 2009;90:415–24.

    Article  CAS  PubMed  Google Scholar 

  100. Micallef MA, Garg ML. Anti-inflammatory and cardioprotective effects of n-3 polyunsaturated fatty acids and plant sterols in hyperlipidemic individuals. Atherosclerosis. 2009;204:476–82.

    Article  CAS  PubMed  Google Scholar 

  101. Ebrahimi M, Ghayour-Mobarhan M, Rezaiean S, Hoseini M, Parizade SM, Farhoudi F, et al. Omega-3 fatty acid supplements improve the cardio-vascular risk profile of subjects with metabolic syndrome, including markers of inflammation and auto-immunity. Acta Cardiol. 2009;64:321–7.

    Article  PubMed  Google Scholar 

  102. Connor WE. N-3 fatty acids from fish and fish oil: panacea or nostrum? Am J Clin Nutr. 2001;74:415–6.

    CAS  PubMed  Google Scholar 

  103. Bang HO, Dyerberg J. Lipid metabolism and ischemic heart disease in Greenland Eskimos. In: Draper HH, editor. Advanced nutrition research. vol. 3. New York: Plenum Press; 1980. p. 1–22.

    Google Scholar 

  104. Kagawa Y, Nishizawa M, Suzuki M. Eicosapolyenoic acids of serum lipids of Japanese islanders with low incidence of cardiovascular diseases. J Nutr Sci Vitaminol. 1982;28:441–53.

    Article  CAS  PubMed  Google Scholar 

  105. Mozaffarian D, Rimm EB. Fish intake, contaminants, and human health: evaluating the risks and the benefits. JAMA. 2006;296:1885–99.

    Article  CAS  PubMed  Google Scholar 

  106. Harris WS, Mozaffarian D, Lefevre M, Toner CD, Colombo J, Cunnanes C, et al. Towards establishing dietary reference intakes for eicosapentaenoic and docosahexaenoic acids. J Nutr. 2009;139:804S–19S.

    Article  CAS  PubMed  Google Scholar 

  107. Leon H, Shibata MC, Sivakumaran S, Dorgan M, Chatterley T, Tsuyuki RT. Effect of fish oil on arrhythmias and mortality: systematic review. BMJ. 2008;337:a2931.

    Article  PubMed  PubMed Central  Google Scholar 

  108. Marik PE, Varon J. Omega-3 dietary supplements and the risk of cardiovascular events: a systematic review. Clin Cardiol. 2009;32:365–72.

    Article  PubMed  Google Scholar 

  109. Yokoyama M, Origasa H, Matsuzaki M, Matsuzawa Y, Saito Y, Ishikawa Y et al., for the Japan EPA lipid intervention study (JELIS) Investigators. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet 2007;369:1090–98.

    Google Scholar 

  110. Yokoyama M, Origasa H, Matsuzaki M, Matsuzawa Y, Saito Y, Ishikawa Y et al. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet 2007;369(9567):1090–8. Erratum in: Lancet 2007;370(9583):220.

    Google Scholar 

  111. Oikawa S, Yokoyama M, Origasa H, et al. for the JELIS Investigators, Japan. Suppressive effect of EPA on the incidence of coronary events in hypercholesterolemia with impaired glucose metabolism: sub-analysis of the Japan EPA Lipid Intervention Study (JELIS). Atherosclerosis 2008;200:135–40.

    Google Scholar 

  112. Sekikawa A, Kuller LH. Coronary heart disease mortality in the United States among black and white men 35–44 years old by state. CVD Prev. 1999;2:212–21.

    Google Scholar 

  113. Sekikawa A, Curb JD, Ueshima H, El-Saed A, Kadowaki T, Abbott RD, et al. Marine-derived n-3 fatty acids and atherosclerosis in Japanese, Japanese-American, and white men: a cross-sectional study. J Am Coll Cardiol. 2008;52(6):417–24.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  114. Burr ML, Ashfield-Watt PA, Dunstan FD, Fehily AM, Breay P, Ashton T, et al. Lack of benefit of dietary advice to men with angina: results of a controlled trial. Eur J Clin Nutr. 2003;57(2):193–200.

    Article  CAS  PubMed  Google Scholar 

  115. Marchioli R, Barzi F, Bomba E, Chieffo C, Di Gregorio D, Di Mascio R, et al. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the GruppoItaliano per lo Studio dellaSopravvivenzanell’InfartoMiocardico (GISSI)-Prevenzione. Circulation. 2002;105(16):1897–903.

    Article  CAS  PubMed  Google Scholar 

  116. GruppoItaliano per lo Studio dellaSopravvivenzanell’Infartomiocardico. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 1999;354(9177):447–455. Erratum in: Lancet 2001;357(9256):642. Lancet 2007;369(9556):106.

    Google Scholar 

  117. Lemaitre RN, King IB, Mozaffarian D, Kuller LH, Tracy RP, Siscovick DS. N-3 polyunsaturated fatty acids, fatal ischemic heart disease, and nonfatal myocardial infarction in older adults: the cardiovascular health study. Am J Clin Nutr. 2003;77(2):319–25.

    CAS  PubMed  Google Scholar 

  118. Tavazzi L, Maggioni AP, Marchioli R, Barlera S, Franzosi MG, Latini R, et al. Gissi-HF investigators, effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet. 2008;372(9645):1223–30.

    Article  PubMed  CAS  Google Scholar 

  119. Eritsland J, Arnesen H, Grønseth K, Fjeld NB, Abdelnoor M. Effect of dietary supplementation with n-3 fatty acids on coronary artery bypass graft patency. Am J Cardiol. 1996;77:31–6.

    Article  CAS  PubMed  Google Scholar 

  120. Yamagishi K, Nettleton JA, Folsom AR. ARIC study investigators. plasma fatty acid composition and incident heart failure in middle—aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J. 2008;156:965–74.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  121. Strøm M, Halldorsson TI, Mortensen EL, Torp-Pedersen C, Sjurdur F. Fish, n-3 fatty acids, and cardiovascular diseases in women of reproductive age: a prospective study in a large national cohort. Hypertension. 2012;59:36–43.

    Article  PubMed  CAS  Google Scholar 

  122. Streppel MT, Ocké MC, Boshuizen HC, Kok FJ, Kromhout D. Long-term fish consumption and n-3 fatty acid intake in relation to (sudden) coronary heart disease death: the Zutphen study. Eur Heart J. 2008;16:2024–30.

    Article  Google Scholar 

  123. Abuissa H, O’Keefe JH, Bybee KA. Statins as antiarrhythmics: a systematic review part II: effects on risk of ventricular arrhythmias. Clin Cardiol. 2009;32(10):549–52.

    Article  PubMed  Google Scholar 

  124. Kotwal S, Jun M, Sullivan D, Perkovic V, Neal B. Omega 3 fatty acids and cardiovascular outcomes: systematic review and meta-analysis. Circ Cardiovasc Qual Outcomes. 2012;5:808–18.

    Article  PubMed  Google Scholar 

  125. Harris WS, Shearer GC. Omega-6 fatty acids and cardiovascular disease: friend, not foe? Circulation. 2014;130:1562–4.

    Article  PubMed  Google Scholar 

  126. Brouwer IA, Zock PL, Camm AJ, Bocker D, Hauer RN, Wever EF, et al. Effect of fish oil on ventricular tachyarrhythmia and death in patients with implantable cardioverter defibrillators: the study on Omega-3 fatty acids and ventricular arrhythmia (SOFA) randomized trial. JAMA;295(22):2613–9.

    Google Scholar 

  127. Rauch B, Schiele R, Schneider S, Diller F, Victor N, Gohlke H, et al. OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction. Circulation. 2010;122(21):2152–9.

    Article  CAS  PubMed  Google Scholar 

  128. Kromhout D, Giltay EJ, Geleijnse JM, Alpha Omega Trial Group. N–3 fatty acids and cardiovascular events after myocardial infarction. N Engl J Med. 2010;363(21):2015–26.

    Article  CAS  PubMed  Google Scholar 

  129. Rizos EC, Ntzani EE, Bika E, Kostapanos MS, Elisaf MS. Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis. JAMA. 2012;308(10):1024–33.

    Article  CAS  PubMed  Google Scholar 

  130. Lewis EJH. Omega-3 fatty acid supplementation and cardiovascular disease events [letter]. JAMA. 2013;309(1):27.

    Article  CAS  PubMed  Google Scholar 

  131. Vlachopoulos C, Richter D, Stefanadis C. Omega-3 fatty acid supplementation and cardiovascular disease events. JAMA. 2013;309(1):28.

    Article  CAS  PubMed  Google Scholar 

  132. Galan P, Kesse-Guyot E, Czernichow S, Briancon S, Blacher J, Hercberg S. Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial. BMJ. 2010;341:c6273.

    Article  PubMed  PubMed Central  Google Scholar 

  133. Svensson M, Schmidt EB, Jrgensen KA, Christensen JH, OPACH Study Group. N-3 fatty acids as secondary prevention against cardiovascular events in patients who undergo chronic hemodialysis: a randomized, placebo-controlled intervention trial. Clin J Am Soc Nephrol. 2006;1(4):780–6.

    Article  CAS  PubMed  Google Scholar 

  134. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998;32(5) supplement 3:S112–9.

    Google Scholar 

  135. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351(13):1296–305.

    Article  CAS  PubMed  Google Scholar 

  136. Lee SM, An WS. Cardioprotective effects of ω-3 PUFAs in chronic kidney disease. Biomed Res Int. 2013;2013:712949.

    PubMed  PubMed Central  Google Scholar 

  137. Katan MB, Zock PL, Mensink RP. Dietary oils, serum lipoproteins, and coronary heart disease. Am J Clin Nutr. 1995;61(6):S1368–73.

    Google Scholar 

  138. Astrup A, Hill JO, Saris WHM, Taubes G. Dietary fat: at the heart of the matter. Science. 2001;293(5531):801–4.

    CAS  PubMed  Google Scholar 

  139. An WS, Lee SM, Son YK, Kim SE, Kim KH, Han JY, et al. Effect of omega-3 fatty acids on the modification of erythrocyte membrane fatty acid content including oleic acid in peritoneal dialysis patients. Prostaglandins Leukot Essent Fatty Acids. 2012;86(1–2):29–34.

    Article  CAS  PubMed  Google Scholar 

  140. An WS, Lee SM, Son YK, Kim SE, Kim HK, Han JY, et al. Omega-3 fatty acid supplementation increases 1, 25-dihydroxyvitamin D and fetuin-A levels in dialysis patients. Nutr Res. 2012;32(7):495–502.

    Article  CAS  PubMed  Google Scholar 

  141. Riediger ND, Othman RA, Suh M, Moghadasian MH. A systemic review of the roles of n-3 fatty acids in health and disease. J Am Diet Assoc. 2009;109(4):668–79.

    Article  CAS  PubMed  Google Scholar 

  142. Kaysen GA. The microinflammatory state in uremia: causes and potential consequences. J Am Soc Nephrol 2001;(12)1549–57.

    Google Scholar 

  143. Muntner P, Hamm LL, Kusek JW, Chen J, Whelton PK, He J. The prevalence of nontraditional risk factors for coronary heart disease in patients with chronic kidney disease. Ann Intern Med. 2004;140(1):9–17.

    Article  PubMed  Google Scholar 

  144. Pischon T, Hankinson SE, Hotamisligil GS, Rifai N, Willett WC, Rimm EB. Habitual dietary intake of n-3 and n-6 fatty acids in relation to inflammatory markers among US men and women. Circulation. 2003;108(2):155–60.

    Article  CAS  PubMed  Google Scholar 

  145. Perunicic-Pekovic GB, Rasic ZR, Pljesa SI, Sobajic SS, Djuricic I, Maletic R, et al. Effect of n-3 fatty acids on nutritional status and inflammatory markers in haemodialysis patients. Nephrology. 2007;12(4):331–6.

    Article  CAS  PubMed  Google Scholar 

  146. Hassan KS, Hassan KS, Hijazi EG, Khazim KO. Effects of omega-3 on lipid profile and inflammation markers in peritoneal dialysis patients. Ren Fail. 2010;32(9):1031–5.

    Article  CAS  PubMed  Google Scholar 

  147. An WS, Kim HJ, Cho KH, Vaziri ND. Omega-3 fatty acid supplementation attenuates oxidative stress, inflammation, and tubulointerstitial fibrosis in the remnant kidney. Am J Physiol Renal Physiol. 2009;297(4):F895–903.

    Article  CAS  PubMed  Google Scholar 

  148. Block RC, Harris WS, Reid KJ, Spertus JA. Omega-6 and trans fatty acids in blood cell membranes: a risk factor for acute coronary syndromes? Am Heart J. 2008;156(6):1117–23.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  149. Paganelli JM, Maixent JM, Duran MJ, Parhizgar R, Pieroni G, Sennoune S. Altered erythrocyte n-3 fatty acids in Mediterranean patients with coronary artery disease. Int J Cardiol. 2001;78(1):27–32.

    Article  CAS  PubMed  Google Scholar 

  150. An WS, Kim SE, Kim KH, Lee S, Park Y, Kim HJ, et al. Comparison of fatty acid contents of erythrocyte membrane in hemodialysis and peritoneal dialysis patients. J Ren Nutr. 2009;19(4):267–74.

    Article  CAS  PubMed  Google Scholar 

  151. Egan BM, Lu G, Greene EL. Vascular effects of non-esterified fatty acids: implications for the cardiovascular risk factor cluster. Prostaglandins Leukot Essent Fatty Acids. 1999;60(5–6):411–20.

    Article  CAS  PubMed  Google Scholar 

  152. Lu G, Greene EL, Nagai T, Egan BM. Reactive oxygen species are critical in the oleic acid-mediated mitogenic signaling pathway in vascular smooth muscle cells. Hypertension. 1998;32(6):1003–10.

    Article  CAS  PubMed  Google Scholar 

  153. Weiner DE, Sarnak MJ. Managing dyslipidemia in chronic kidney disease. J Gen Intern Med. 2004;19(10):1045–52.

    Article  PubMed  PubMed Central  Google Scholar 

  154. Shobeiri N, Pang J, Adams MA, Holden RM. Cardiovascular disease in an adenine-induced model of chronic kidney disease: the temporal link between vascular calcification and haemodynamic consequences. J Hypertens. 2013;31(1):160–8.

    Article  CAS  PubMed  Google Scholar 

  155. Nishizawa H, Hamazaki K, Hamazaki T, Fujioka S, Sawazaki S. The relationship between tissue RBC n-3 fatty acids and pulse wave velocity. In Vivo. 2006;20(2):307–10.

    CAS  PubMed  Google Scholar 

  156. Szweras M, Liu D, Partridge EA, Pawling J, Sukhu B, Clokie C, et al. Alpha 2-HS glycoprotein/fetuin, a transforming growth factor-beta/bone morpho-genetic protein antagonist, regulates postnatal bone growth and remodeling. J Biol Chem. 2002;277(22):19991–7.

    Article  CAS  PubMed  Google Scholar 

  157. Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, Lanier K, et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation. 2008;117(4):503–11.

    Article  CAS  PubMed  Google Scholar 

  158. Melamed ML, Michos ED, Post W, Astor B. 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med. 2008;168(15):1629–37.

    Article  PubMed  PubMed Central  Google Scholar 

  159. Artaza JN, Mehrotra R, Norris KC. Vitamin D and the cardiovascular system. Clin J Am Soc Nephrol. 2009;4(9):1515–22.

    Article  CAS  PubMed  Google Scholar 

  160. Harris WS, Von Schacky C. The omega-3 index: a new risk factor for death from coronary heart disease? Prev Med. 2004;39(1):212–20.

    Article  CAS  PubMed  Google Scholar 

  161. Harris WS, Sands SA, Windsor SL, Ali HA, Stevens TL, Magalski A, et al. Omega-3 fatty acids in cardiac biopsies from heart transplantation patients: correlation with erythrocytes and response to supplementation. Circulation. 2004;110:1645–9.

    Article  CAS  PubMed  Google Scholar 

  162. Metcalf RG, James MJ, Gibson RA, Edwards JR, Stubberfield J, Stuklis R, et al. Effects of fish-oil supplementation on myocardial fatty acids in humans. Am J Clin Nutr. 2007;85:1222–8.

    CAS  PubMed  Google Scholar 

  163. Aarsetøy H, Pönitz HV, Nilsen OB, Grundt H, Harris WS, Nilsen DW. Low levels of cellular omega-3 increase the risk of ventricular fibrillation during the acute ischaemic phase of a myocardial infarction. Resuscitation. 2008;78:258–64.

    Article  PubMed  CAS  Google Scholar 

  164. Aarsetoey H, Aarsetoey R, Lindner T, Staines H, Harris WS, Nilsen DW. Low levels of the omega-3 index are associated with sudden cardiac arrest and remain stable in survivors in the subacute phase. Lipids. 2011;46:151–61.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  165. Siscovick DS, Raghunathan TE, King I, Weinmann S, Wicklund KG, Albright J, et al. Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. JAMA. 1995;274:1363–7.

    Article  CAS  PubMed  Google Scholar 

  166. Aarsetoey H, Ponitz V, Grundt H, Staines H, Harris WS, Nilsen DW. (n-3) Fatty acid content of red blood cells does not predict risk of future cardiovascular events following an acute coronary syndrome. J Nutr. 2009;139:507–13.

    Article  CAS  PubMed  Google Scholar 

  167. Von Schacky C. Omega-3 fatty acids vs. cardiac disease-the contribution of the omega-3 index. Cell Mol Biol (Noisy-le-grand). 2010;56:93–101.

    Google Scholar 

  168. Harris WS, Kris-Etherton PM, Harris KA. Intakes of long-chain omega-3 fatty acid associated with reduced risk for death from coronary heart disease in healthy adults. Curr Atheroscler Rep. 2008;10:503–9.

    Article  CAS  PubMed  Google Scholar 

  169. Kris-Etherton PM, Harris WS, Appel LJ. Omega-3 fatty acids and cardiovascular disease: new recommendations from the American Heart Association. Arterioscler Thromb Vasc Biol. 2003;23:151–2.

    Article  CAS  PubMed  Google Scholar 

  170. Simopoulos AP, Leaf A, Salem N Jr. Workshop statement on the essentiality of and recommended dietary intakes for omega-6 and omega-3 fatty acids. Prostaglandins Leukot Essent Fatty Acids. 2000;63:119–21.

    Article  CAS  PubMed  Google Scholar 

  171. Fares H, Lavie CJ, DiNicolantonio JJ, O’Keefe JH, Milani RV. Omega-3 fatty acids: a growing ocean of choices. Curr Atheroscler Rep. 2014;16:389.

    Article  PubMed  CAS  Google Scholar 

  172. Davidson MH, Stein EA, Bays HE, Maki KC, Doyle RT, Shalwitz RA, et al. Efficacy and tolerability of adding prescription omega-3 fatty acids 4 g/d to simvastatin 40 mg/d in hypertriglyceridemic patients: an 8-week, randomized, double-blind, placebo-controlled study. Clin Ther. 2007;29:1354–67.

    Article  CAS  PubMed  Google Scholar 

  173. Bays HE, Ballantyne CM, Kastelein JJ, Isaacsohn JL, Braeckman RA, Soni PN. Eicosapentaenoic acid ethyl ester (AMR101) therapy in patients with very high triglyceride levels (from the multi-center, placebo-controlled, randomized, double-blind, 12-week study with an open-label extension [MARINE] trial). Am J Cardiol. 2011;108:682–90.

    Article  CAS  PubMed  Google Scholar 

  174. Filion KB, El Khoury F, Bielinski M, Schiller I, Dendukuri N, Brophy JM. Omega-3 fatty acids in high-risk cardiovascular patients: a meta-analysis of randomized controlled trials. BMC Cardiovasc Disord. 2010;10:24.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  175. Chalupka S. Omega-3 polyunsaturated fatty acid in primary and secondary cardiovascular disease prevention. AAOHN J. 2009;57(11):480.

    PubMed  Google Scholar 

  176. Park K, Mozaffarian D. Omega-3 fatty acids, mercury, and selenium in fish and the risk of cardiovascular diseases. Curr Atheroscler Rep. 2010;12(6):414–22.

    Article  CAS  PubMed  Google Scholar 

  177. Judge MP, Harel O, Lammi-Keefe CJ. Maternal consumption of a docosahexaenoic acid-containing functional food during pregnancy: benefit for infant performance on problem-solving but not on recognition memory tasks at age 9 mo. Am J ClinNutr. 2007;85:1572–7.

    CAS  Google Scholar 

  178. Birch EE, Garfield S, Hoffman DR, Uauy R, Birch DG. A randomized controlled trial of early dietary supply of long-chain polyunsaturated fatty acids and mental development in term infants. Dev Med Child Neurol. 2000;42:174–81.

    Article  CAS  PubMed  Google Scholar 

  179. Bernardi JR, de Escobar RS, Ferreira CF, Sileira PP. Fetal and neonatal levels of omega-3: effects on neurodevelopment, nutrition, and growth. Sci World J. 2012;2012:202473.

    Google Scholar 

  180. Crawford MA, Costeloe K, Ghebremeskel K, Phylactos A, Skirvin L, Stacey F. Are deficits of arachidonic and docosahexaenoic acids responsible for the neural and vascular complications of preterm babies? Am J Clin Nutr. 1997;66(4):1032S–41S.

    CAS  PubMed  Google Scholar 

  181. DiNicolantonio JJ, Niazi AK, O’Keefe JH, Lavie CJ. Explaining the recent fish oil trial “failures”. J Glycomics Lipidomics. 2013;3(1):e112.

    Google Scholar 

  182. Montori VM, Farmer A, Wollan PC, Dinneen SF. Fish oil supplementation in type 2 diabetes: a quantitative systematic review. Diabetes Care. 2000;23(9):1407–15.

    Article  CAS  PubMed  Google Scholar 

  183. Hartweg J, Farmer AJ, Perera R, Holman RR, Neil HAW. Meta-analysis of the effects of n-3 polyunsaturated fatty acids on lipoproteins and other emerging lipid cardiovascular risk markers in patients with type 2 diabetes. Diabetologia. 2007;50(8):1593–602.

    Article  CAS  PubMed  Google Scholar 

  184. Hu FB, Cho E, Rexrode KM, Albert CM, Manson JE. Fish and long-chain omega-3 fatty acid intake and risk of coronary heart disease and total mortality in diabetic women. Circulation. 2003;107(14):1852–7.

    Article  PubMed  Google Scholar 

  185. Nettleton JA, Katz R. n-3 long-chain polyunsaturated fatty acids in type 2 diabetes: a review. J Am Diet Assoc. 2005;105(3):428–40.

    Article  CAS  PubMed  Google Scholar 

  186. Geleijnse JM, Giltay EJ, Grobbee DE, Donders AR, Kok FJ. Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials. J Hypertens. 2002;20(8):1493–9.

    Article  CAS  PubMed  Google Scholar 

  187. Campos H, Baylin A, Willett WC. Alpha-linolenic acid and risk of nonfatal acute myocardial infarction. Circulation. 2008;118:339–45.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  188. Tillander V, Bjørndal B, Bohov P, Burri L, Skorve J, Berge RK, et al. Fish oil and krill oil supplementations differentially regulate lipid catabolic and synthetic pathways in mice. Nutr Metab (Lond). 2014;11:20.

    Article  CAS  Google Scholar 

  189. Kumar S, Sutherland F, Morton JB, Lee G, Morgan J, Wong J, et al. Long-term omega-3 polyunsaturated fatty acid supplementation reduces the recurrence of persistent atrial fibrillation after electrical cardioversion. Heart Rhythm. 2012;9(4):483–91.

    Article  PubMed  Google Scholar 

  190. Patel D, Shaheen M, Venkatraman P, Armaganijan L, Sanchez JE, et al. Omega-3 polyunsaturated fatty acid supplementation reduced atrial fibrillation recurrence after pulmonary vein antrum isolation. Indian Pacing Electrophysiol J. 2009;9:292–8.

    PubMed  PubMed Central  Google Scholar 

  191. Bairati I, Roy L, Meyer F. Double-blind, randomized, controlled trial of fish oil supplements in prevention of recurrence of stenosis after coronary angioplasty. Circulation. 1992;85:950–6.

    Article  CAS  PubMed  Google Scholar 

  192. Maresta A, Balduccelli M, Varani E, Marzilli M, Galli C, Heiman F, ESPRIT Investigators, et al. Prevention of postcoronary angioplasty restenosis by omega-3 fatty acids: main results of the Esapent for Prevention of Restenosis ITalian Study (ESPRIT). Am Heart J. 2002;143:E5.

    Article  PubMed  Google Scholar 

  193. Calò L, Bianconi L, Colivicchi F, Lamberti F, Loricchio ML, de Ruvo E, et al. N-3 Fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a randomized, controlled trial. J Am Coll Cardiol. 2005;45:1723–8.

    Article  PubMed  CAS  Google Scholar 

  194. Heidt MC, Vician M, Stracke SK, Stadlbauer T, Grebe MT, Boening A, et al. Beneficial effects of intravenously administered N-3 fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a prospective randomized study. Thorac Cardiovasc Surg. 2009;57:276–80.

    Article  CAS  PubMed  Google Scholar 

  195. Yamagishi K, Iso H, Date C, Fukui M, Wakai K, Kikuchi S, et al. Japan Collaborative Cohort Study for Evaluation of Cancer Risk Study Group. Fish, omega-3 polyunsaturated fatty acids, and mortality from cardiovascular diseases in a nationwide community-based cohort of Japanese men and women: the JACC (Japan Collaborative Cohort Study for Evaluation of Cancer Risk) Study. J Am Coll Cardiol 2008;52:988–96.

    Google Scholar 

  196. Kromhout D, Giltay EJ, Geleijnse JM, Alpha Omega Trial Group. n-3 Fatty acids and cardiovascular events after myocardial infarction. N Engl J Med. 2010;363:2015–26.

    Article  CAS  PubMed  Google Scholar 

  197. Brouwer IA, Raitt MH, Dullemeijer C, Kraemer DF, Zock PL, Morris C, et al. Effect of fish oil on ventricular tachyarrhythmia in three studies in patients with implantable cardioverter defibrillators. Eur Heart J. 2009;30:820–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  198. Kowey PR, Reiffel JA, Ellenbogen KA, Naccarelli GV, Pratt CM. Efficacy and safety of prescription omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: a randomized controlled trial. JAMA. 2010;304:2363–72.

    Article  CAS  PubMed  Google Scholar 

  199. Reis GJ, Boucher TM, Sipperly ME, Silverman DI, McCabe CH, Baim DS, et al. Randomised trial of fish oil for prevention of restenosis after coronary angioplasty. Lancet. 1989;2(8656):177–81.

    Article  CAS  PubMed  Google Scholar 

  200. Bridgewater B, Saravanan P, O’Neill SC, West AL, Calder PC, Davidson NC, et al. Omega-3fatty acid supplementation does not reduce risk of atrial fibrillation after coronary artery bypass surgery: a randomized, double-blind, placebo-controlled clinical trial. Circ Arrhythmia Electrophysiol. 2010;3:46–53.

    Article  CAS  Google Scholar 

  201. Farquharson AL, Metcalf RG, Sanders P, Stuklis R, Edwards JR, Gibson RA, et al. Effect of dietary fish oil on atrial fibrillation after cardiac surgery. Am J Cardiol. 2011;108:851–6.

    Article  CAS  PubMed  Google Scholar 

  202. Dijkstra SC, Brouwer IA, van Rooij FJ, Hoffman A, Witteman JC, Jeleijnse JM. Intake of very long chain n-3 fatty acids from fish and the incidence of heart failure: the rotterdam study. Eur J Heart Fail. 2009;11:922–8.

    Article  CAS  PubMed  Google Scholar 

  203. Belin RJ, Greenland P, Martin L, Oberman A, Tinker L, Robinson J, et al. Fish intake and the risk of incident heart failure: the Women’s Health Initiative. Circ Heart Fail. 2011;4:404–13.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Endocrine and Diabetes Unit, Christian Medical College and Hospital, Ludhiana, Punjab, 141008, India

    Soumia Peter & Jubbin Jagan Jacob

Authors
  1. Soumia Peter
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jubbin Jagan Jacob
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jubbin Jagan Jacob .

Editor information

Editors and Affiliations

  1. Real Nutrition Laboratory, Bharati Vidyapeeth University Real Nutrition Laboratory, Dhankawadi, India

    Mahabaleshwar V. Hegde

  2. Center for Innovation in Nutrition Health Disease, Bharati Vidyapeeth University , Dhankawadi Pune, India

    Anand Arvind Zanwar

  3. Western IRB Medical Vice Chair, Puyallup, Washington, USA

    Sharad P. Adekar

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Peter, S., Jacob, J.J. (2016). Role of Omega-3 Fatty Acids in Cardiovascular Disorders. In: Hegde, M., Zanwar, A., Adekar, S. (eds) Omega-3 Fatty Acids. Springer, Cham. https://doi.org/10.1007/978-3-319-40458-5_37

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-40458-5_37

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-40456-1

  • Online ISBN: 978-3-319-40458-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation